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Introduction
The mean age of  diagnosis of new oral squamous cell carcinoma (OSCC) cases is around 60 
years with less than 5% of all patients aged 45 years or younger (Taybos, 2003). Oral tongue 
squamous cell carcinoma (OTSCC) is the most common, and presents with the worst prognosis (Ng et 
al., 2017). Several risk factors have been associated with OTSCC, many of which appear to be more 
related to older age (Farquhar et al., 2018). Young OTSCC patients lack these risk factors or when 
present, they have much shorter exposure time to the risk factors, suggesting different  genomic and 
molecular changes than seen in older OTSCC patients (Llewellyn et al., 2004). 
Globally the increased incidence of OTSCC in the past four decades is partly attributable to increased 
cases among younger patients, with some countries experiencing up to four fold increase (Muller et 
al., 2008, Ng et al., 2017). Suggestions for this increase included oncogenic virus infection, exposure 
to yet unidentified mutagens, alterations in diet or oral microbiome and inherited genetic defects 
predisposing to OTSCC (Gu et al., 2019). However, conflicting reports about clinical behavior and 
prognosis of young OTSCC patients compared with older patients abound, as reviewed by different 
groups (Campbell et al., 2018, Paderno et al., 2018). 
Previous studies have focused mainly on the clinical outcome and molecular characteristics, 
but not on the histopathological characteristics to explain the possible differences and similarities of 
OTSCC between young and older patients. The purpose of this study was therefore to compare 
several OTSCC epithelial and stromal histological features with independent prognostic potential like 
tumour budding (TB), depth of invasion (DOI) and worst pattern of invasion (WPOI) (Almangush et 
al., 2015, Almangush et al., 2014), tumour-stroma ratio (TSR) (Almangush et al., 2018) and stromal 
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tumour grade and perineural invasion (PNI) in patients with early-stage OTSCC between patients ≤45 
years and those >60 years.
Methods
A previously studied cohort of 311 patients treated for early-stage (cT1-2N0M0) OTSCC from 1979 
to 2009 at six university hospitals in Finland and Brazil was used (Almangush et al., 2018). Only 42 
patients were  aged ≤ 45 years. These cases were extracted and matched according to the clinical 
tumour stage (stage I or II), gender and centers of management with patients >60-year-old. Patients 
aged 46-60 years were excluded because their cancer-related events rate were much more similar to 
the young patients than the elderly group.
The histopathological features extracted for comparison included those often included in pathology 
reports such as WHO tumor grade (Kademani et al., 2005), DOI (Brierley et al., 2017), PNI 
(Brandwein-Gensler et al., 2010), and WPOI (Brandwein-Gensler et al., 2010), in addition to TB 
(Almangush et al., 2014), TSR (Almangush et al., 2018), TILs (Heikkinen et al., 2019) and histologic 
risk score (HRS) (Brandwein-Gensler et al., 2010) (Table 1). These histopathologic features were 
scored as illustrated in Figure 1. The procedures for evaluating the parameters studied are outlined in 
the published studies (Tam et al., 2019, Almangush et al., 2015, Almangush et al., 2018, Heikkinen et 
al., 2019, Brandwein-Gensler et al., 2010). Cross-tabulation analysis of the differences in 
histopathologic characteristics and other variables between paired patients groups were done. 
Statistical significance was evaluated using McNemar (2x2 tables) or McNemar-Bowker (3x3 tables) 
tests as the compared groups were not considered independent, since the subjects were chosen based 
on similar characteristics. IBM SPSS software version 23 was used for statistical analysis.
Results 
With minor differences, the WHO grade, depth of invasion and perineural invasion bear  close 
resemblance in both groups (Table 1). Regarding other histological characteristics, the young group 
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older patients. Similarly, higher WPOI (86% vs. 69%)  and TSR (36% vs 31%) were noted more in 
young patients compared with older patients. Low TIL was observed in 14% of tumours in the young 
group compared with 17% in the older group.  No statistically significant difference was observed 
between the two groups in all the parameters evaluated (P>0.05) (Table 1).  
Discussion  
Some workers reviewed the several conflicting reports regarding the prognosis of OTSCC in young 
patients in comparison to older patients among American patients (Campbell et al., 2018).   They 
adduced several reasons for this incongruity, including lack of statistical power in studies, absence of 
a control group of older patients, and use of different survival end points thereby making comparison 
between studies difficult. In general, the more recent studies, with few exceptions, have reported 
better survival outcome for younger patients but the controversy still lingers (Campbell et al., 2018, 
Paderno et al., 2018). 
We have earlier established that some histopathological characteristics are independently 
associated with prognosis of early-stage OTSCC patients (Almangush et al., 2014, Almangush et al., 
2015, Almangush et al., 2018, Heikkinen et al., 2019). A previous study which compared stromal 
myofibroblast quantity in matched young and older OTSCC patients found no significant differences 
between both groups (Fonseca et al., 2014). Increased stromal myofibroblasts has been associated 
with poor prognosis in OTSCC (Bello et al., 2011). In a previous study, we suggested that stromal 
myofibroblasts are probably more influential in late-stage OTSCC than early stages (Almangush et 
al., 2014).
In this present study, no significant differences in the histopathological characteristics of 
early-stage OTSCC was seen between clinically matched young and elderly groups. Based on this, it 
is therefore not possible to suggest or conclude that the management protocol for early-stage OTSCC 
should be different between the two groups. This lack of difference in the histopathological features 
turns the attention to genomic and molecular differences. Some studies have reported lack of 
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sequencing and copy number analysis (Pickering et al., 2014). However, diverse copy number 
variations seemed to be related to worse prognostic phenotype within young patients (Gu et al., 2019). 
DNA ploidy studies have suggested increased genomic instability in young OTSCC patients with 
increased aneuploidy, tetraploidy and mean higher DNA index noted (Santos-Silva et al., 2011). A 
recent review on molecular testing concluded that OTSCC is essentially similar in young and older 
patients (Campbell et al., 2018). Genetic studies are usually limited to a small number of patients, and 
more needs to be done to establish the true nature of OTSCC in young patients, particularly early-
stage disease.
In summary, this study did not find any significant differences in the histopathologic features 
of early-stage OTSCC between the young (≤ 45 years) and the elderly patients (>60 years) in our 
multi-institutional series. This invites further validation studies in larger cohorts of early-stage 
OTSCC. More refined genomic, metagenomics and molecular investigations in these patient groups 
are also warranted to elucidate whether their treatment protocols should be developed differently. 
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Table 1: Frequency and percentage distributions of various tumor-related epithelial and stromal 
histopathologic characteristics among young (45 years) and old patients (>60 years). 
 
Variable  Young (≤45 yrs) 
(n=42) 





Tumor grade   0.948 
 Well-differentiated 13 (31%) 15 (36%)  
 Moderately-differentiated 20 (48%) 18 (43%)  
 Poorly-differentiated 9 (21%) 9 (21%)  
Depth of invasion#   0.804 
 Superficial  14 (33%) 16 (38%)  
 Deep 28 (67%) 26 (69%)  
Perineural invasion    0.727 
 Absent 38 (91%) 36 (86%)  
 Present   4 (9%)   6 (14%)  
Tumor budding#   0.077 
 Low intensity 24 (57%) 32 (76%)  
 High intensity 18 (43%) 10 (24%)  
Histologic risk score##    0.225 
 Low-risk (0) 1 (2.4%) 1 (2.4%)  
 Intermediate-risk (1-2) 9 (21.4%) 14 (33.3%)  
 High-risk (≥3) 32 (76.2) 27 (64.3%)  
Worst pattern of invasion    0.065 
 Cohesive 6 (14%) 13 (31%)  
 Infiltrative 36 (86%) 29 (69%)  
Tumor - stroma ratio (TSR)   0.180 
 Low 27 (64%) 33 (79%)  
 High  15 (36%) 9 (31%)  
Tumor-infiltrating lymphocytes    > 0.999 
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 High response 36 (86%) 34 (83%)  
 
*
 P value of McNemar test (2x2 table) or McNemar-Bowker (3x3 table) test. 
#
Depth of invasion was classified as superficial when less than 4mm. High tumor budding was 
defined as presence of 5 or more tumor buds (see figure 1) at the invasive front of the tumor. 
Worst pattern of invasion, TSR and TIL are briefly explained in Figure 1. 
##
 Histologic risk score comprises both tumor cell-related and stromal components (WPOI, 
lymphocytic host response and perineural invasion). Final score used to categorize cases for HRS 
are in parenthesis.  
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